| 2026/03 | Animal Research at Roche | Position | PDF |
| 2026/02 | Mental Health and Wellbeing | Fact Sheet | PDF |
| 2026/02 | Compliance | Fact Sheet | PDF |
| 2026/02 | Eco-balance | Fact Sheet | PDF |
| 2026/02 | Emissions to water | Fact Sheet | PDF |
| 2026/02 | Energy Consumption | Fact Sheet | PDF |
| 2026/02 | Greenhouse Gas Emissions | Fact Sheet | PDF |
| 2026/02 | Other emissions to air | Fact Sheet | PDF |
| 2026/02 | Roche illness rate and occupational illnesses | Fact Sheet | PDF |
| 2026/02 | Supporting Biodiversity | Fact Sheet | PDF |
| 2026/02 | Use of water | Fact Sheet | PDF |
| 2026/02 | Waste Management | Fact Sheet | PDF |
| 2026/01 | Roche Climate-Related Claims
Disclosure Statement | Position | PDF |
| 2026/01 | Policy on Safety, Security, Health and Environmental Protection | Policy | PDF |
| 2025/03 | Employment Policy (English) | Policy | PDF |
| 2025/02 | Greenhouse Gas Emissions (Scope 3) | Fact Sheet | PDF |
| 2025/01 | Roche Global Policy on Continued Access to Investigational Interventions | Policy | PDF |
| 2024/08 | Roche’s Approach to Tax – General Description and Principles | Principles | PDF |
| 2024/08 | Roche Position on TRIPS and the Doha Declaration | Position | PDF |
| 2024/07 | Pricing | Position | PDF |
| 2024/04 | Roche Position on Race, Ethnicity, and Genetic Ancestry
Application and Use in Clinical Trials and Product Development | Position | PDF |
| 2024/02 | Six bold actions for regulatory reform (EU) 2024 | Position | PDF |
| 2023/11 | Roche AI Ethics Principles | Principles | PDF |
| 2023/11 | Risk Management | Policy | PDF |
| 2023/11 | Pre-Approval Access to Investigational Medicinal Products | Position | PDF |
| 2023/09 | Roche Policy on sharing of clinical study information | Policy | PDF |
| 2023/07 | Similar Biotherapeutic Products - Biosimilars | Position | PDF |
| 2023/03 | Roche Data Ethics Principles | Principles | PDF |
| 2023/02 | Group Insider Policy | Policy | PDF |
| 2023/02 | Human Stem Cells | Position | PDF |
| 2023/02 | Position on Human Specimen Resources (Biobanks) | Position | PDF |
| 2023/01 | Supplier Code of Conduct (German) | Guidelines | PDF |
| 2023/01 | Supplier Code of Conduct (English) | Guidelines | PDF |
| 2022/11 | Six bold actions for regulatory reform (EU) | Position | PDF |
| 2022/11 | Roche’s Position on Access to & Use of Real World Data | Position | PDF |
| 2022/10 | Roche FAQ Clinical Research | FAQs | PDF |
| 2022/07 | Roche position on incentivising the development and appropriate use of new antibiotics | Policy | PDF |
| 2022/06 | EFPIA Disclosure Code Self-Certification Scheme | Position | PDF |
| 2022/05 | Behaviour in Business (English) | Guidelines | PDF |
| 2022/05 | Behaviour in Business (German) | Guidelines | PDF |
| 2022/05 | Behaviour in Business (French) | Guidelines | PDF |
| 2022/05 | Responsible Sharing of Scientifically Credible Information on the portal | Position | PDF |
| 2021/09 | Waste Management and Circular Economy | Position | PDF |
| 2021/07 | Water | Position | PDF |
| 2021/06 | EFPIA Disclosure Code Self-Certification Scheme | Policy | PDF |
| 2021/06 | Roche Position on Enabling Access through Collaboration | Position | PDF |
| 2021/05 | Roche's Position on Partnering with Patient Communities | Position | PDF |
| 2021/02 | Roche Position on Health Technology Assessment | Position | PDF |
| 2020/06 | EFPIA Disclosure Code Self-Certification Scheme | Policy | PDF |
| 2020/04 | Biodiversity | Position | PDF |
| 2020/04 | Clinical Research | Position | PDF |
| 2020/04 | Counterfeiting | Position | PDF |
| 2020/04 | Landfills / Contaminated Soil | Position | PDF |
| 2020/04 | Personalised Healthcare | Position | PDF |
| 2020/04 | Pharmaceuticals in the Environment | Position | PDF |
| 2020/04 | R&D for Neglected Tropical Disease | Position | PDF |
| 2020/04 | Roche Position on Counterfeit and Falsified Pharmaceutical & Diagnostic Products | Position | PDF |
| 2020/04 | Product Stewardship | Position | PDF |
| 2020/04 | Human Rights | Position | PDF |
| 2020/04 | Human Genetic and Genomic Research | Position | PDF |
| 2019/07 | EFPIA Disclosure Code Self-Certification Scheme | Policy | PDF |
| 2018/12 | Roche Directive Collaborating with Patient Groups and Patients | Guidelines | PDF |
| 2018/10 | Intellectual Property, Fueling Innovation & Advancing Healthcare | Position | PDF |
| 2018/10 | Certificate on Roche's Sustainability Commitments, Initiatives and Performance | Fact Sheet | PDF |
| 2018/05 | Working with Government Officials | Guidelines | PDF |
| 2018/05 | Philanthropic Donations and Non-commercial Sponsorship | Policy | PDF |
| 2017/06 | EFPIA Disclosure Code Self-Certification Scheme | Policy | PDF |
| 2017/05 | Benefits - Switzerland | Brochure | PDF |
| 2016/06 | Counterfeit Medicinal products | FAQs | PDF |
| 2016/03 | Behaviour in Competition | Guidelines | PDF |
| 2016/03 | Behaviour in Competition (German) | Guidelines | PDF |
| 2015/05 | Roche Specimen Repositories | FAQs | PDF |